Skip to main content
eScholarship
Open Access Publications from the University of California

Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy.

  • Author(s): Kouri, Naomi
  • Ross, Owen A
  • Dombroski, Beth
  • Younkin, Curtis S
  • Serie, Daniel J
  • Soto-Ortolaza, Alexandra
  • Baker, Matthew
  • Finch, Ni Cole A
  • Yoon, Hyejin
  • Kim, Jungsu
  • Fujioka, Shinsuke
  • McLean, Catriona A
  • Ghetti, Bernardino
  • Spina, Salvatore
  • Cantwell, Laura B
  • Farlow, Martin R
  • Grafman, Jordan
  • Huey, Edward D
  • Ryung Han, Mi
  • Beecher, Sherry
  • Geller, Evan T
  • Kretzschmar, Hans A
  • Roeber, Sigrun
  • Gearing, Marla
  • Juncos, Jorge L
  • Vonsattel, Jean Paul G
  • Van Deerlin, Vivianna M
  • Grossman, Murray
  • Hurtig, Howard I
  • Gross, Rachel G
  • Arnold, Steven E
  • Trojanowski, John Q
  • Lee, Virginia M
  • Wenning, Gregor K
  • White, Charles L
  • Höglinger, Günter U
  • Müller, Ulrich
  • Devlin, Bernie
  • Golbe, Lawrence I
  • Crook, Julia
  • Parisi, Joseph E
  • Boeve, Bradley F
  • Josephs, Keith A
  • Wszolek, Zbigniew K
  • Uitti, Ryan J
  • Graff-Radford, Neill R
  • Litvan, Irene
  • Younkin, Steven G
  • Wang, Li-San
  • Ertekin-Taner, Nilüfer
  • Rademakers, Rosa
  • Hakonarsen, Hakon
  • Schellenberg, Gerard D
  • Dickson, Dennis W
  • et al.
Abstract

Corticobasal degeneration (CBD) is a neurodegenerative disorder affecting movement and cognition, definitively diagnosed only at autopsy. Here, we conduct a genome-wide association study (GWAS) in CBD cases (n=152) and 3,311 controls, and 67 CBD cases and 439 controls in a replication stage. Associations with meta-analysis were 17q21 at MAPT (P=1.42 × 10(-12)), 8p12 at lnc-KIF13B-1, a long non-coding RNA (rs643472; P=3.41 × 10(-8)), and 2p22 at SOS1 (rs963731; P=1.76 × 10(-7)). Testing for association of CBD with top progressive supranuclear palsy (PSP) GWAS single-nucleotide polymorphisms (SNPs) identified associations at MOBP (3p22; rs1768208; P=2.07 × 10(-7)) and MAPT H1c (17q21; rs242557; P=7.91 × 10(-6)). We previously reported SNP/transcript level associations with rs8070723/MAPT, rs242557/MAPT, and rs1768208/MOBP and herein identified association with rs963731/SOS1. We identify new CBD susceptibility loci and show that CBD and PSP share a genetic risk factor other than MAPT at 3p22 MOBP (myelin-associated oligodendrocyte basic protein).

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View